La vendita allo scoperto per Hippo Holdings dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Hippo Holdings. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Hippo Holdings (NYSE:HIPO) Azioni, Report sulle vendite allo scoperto

Hippo Holdings

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the Company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

Hippo Holdings Inc

<p>Highlighting Tumor-Targeted T Cell Activation and CD40 Modulation in Solid Tumors at SITC 2024</p>


Biotech

News

General

MOLN

Molecular Partners Unveils Preclinical Proof-Of-Concept For CD3 Switch-DARPin T Cell Engager And Clinical Biomarker Insights For MP0317

Guidance

Sprout Social Sees Q4 Revenue $106.3M-$107.1M; Q4 Adj. EPS $0.15-$0.16.

<p>Ameresco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NYSE">AMRC</a>) affirms FY2024 Adj EPS guidance from $1.15-1.35 to $1.15-1.35 vs $1.14 analyst estimate. Affirms FY2024 sales outlook from $1.70 billion-1.80 billion to $1.70 billion-1.80 billion vs $1.74 billion estimate.</p>


AMRC

Ameresco Affirms FY2024 Adj EPS Guidance from $1.15-1.35 to $1.15-1.35 vs $1.14 Est; Affirms FY2024 Sales Guidance from $1.70B-1.80B to $1.70B-1.80B vs $1.74B Est

<p>Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.49) by 77.55 percent. This is a 69.44 percent increase over losses of $(0.36) per share from the same period last year.  The company reported quarterly sales of $88.83 million which beat the analyst consensus estimate of $84.14 million by 5.58 percent.  This is a 5.80 percent increase over sales of $83.97 million the same period last year.</p>


Earnings

Earnings Beats

INGN

Inogen Q3 Adj $(0.11) Beats $(0.49) Estimate, Sales $88.83M Beat $84.14M Estimate

<p>CarGurus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARG#NASDAQ">CARG</a>) is looking for Q4 Adj EPS of $0.50-0.55 vs $0.46 analyst estimate. sees sales of $219.000 million-239.000 million vs $225.58 million estimate.</p>


CARG

CarGurus Sees Q4 Adj EPS $0.50-0.55 vs $0.46 Est; Sees Sales $219.000M-239.000M vs $225.58M Est

W&T Offshore Sees FY24 Total Equivalents (MBoe) 11,900 – 13,267

W&T Offshore Sees Q4 Total Equivalents (MBoe) 2,927-3,253

IONQ

IonQ Partners With imec To Enhance Quantum Computing Scale And Performance Using Photonic Integrated Circuits, Aiming To Increase Qubit Count, Improve System Efficiency, And Reduce Costs For Next-Gen Quantum Computers

Sprout Social Sees FY24 Revenue $405.1M-$405.9M Vs $405.535M Est; FY24 Adj. EPS $0.46-$0.47 Vs $0.46 Est.

<p><strong>FY2025 Guidance</strong></p>
<p>&nbsp;</p>
<ul>
<li>The Company is providing preliminary FY2025 guidance of $12.00 Adjusted Net Income per Diluted Share with the expectation of being a full corporate taxpayer throughout the year (20%-25% effective tax rate).</li>
</ul>


SEZL

Sezzle Is Providing Preliminary FY25 Guidance Of $12.00 Adjusted Net Income Per Diluted Share With The Expectation Of Being A Full Corporate Taxpayer Throughout The Year (20%-25% Effective Tax Rate) Vs $10.09 Est.

SEMR

SEMrush Sees Q4 Total Revenue $100.8M-$101.8M vs $101.03M Est., Sees FY24 Total Revenue $375M-$376M vs $374.45M Est.

<p><strong>Block, Inc. </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) reported its third-quarter results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/b41823717/block-announces-third-quarter-2024-results">details from the report.&nbsp;</a></p>
<p><strong>The Details:&nbsp;</strong>Block reported quarterly earnings of 88 cents per share, which beat the analyst consensus estimate of 87 cents. Quarterly revenue came in at $5.97 billion which missed the analyst consensus estimate of $6.24 billion and is an increase over sales of $5.617 billion from the same period last year.</p>
<ul>
<li>Square generated a gross profit of $932 million, up 16% year-over-year.</li>
<li>Cash App generated a gross profit of $1.31 billion, up 21% year-over-year.</li>
</ul>
<p><strong>Read Next: </strong><a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers"><strong>What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</strong></a></p>
<p>&#8220;We outperformed our gross profit and profitability guidance in the third quarter of 2024. Gross profit grew 19% year over<br />year to $2.25 billion. Cash App continued its strong performance with gross profit growth of 21% year over year, driven primarily by growth in inflows per active and an increase in monetization rate,&#8221; Block wrote in a letter to shareholders.</p>
<p>&#8220;There was strong performance across Cash App Card, Cash App Borrow and our BNPL platform. Square gross profit grew 16% year over year in the third quarter, in line with our expectations, behind strength in our software and integrated payments and banking products,&#8221; the company added.</p>
<p><strong>SQ Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Block shares are down 7.69% after-hours at $69.25 at the time of publication Thursday.</p>
<p><strong>Read More:&nbsp;</strong></p>
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction"><strong>Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Fintech news covering the emerging Financial Technology services sector

Fintech

After-Hours Center

Movers

Block Shares Sink After Mixed Q3 Results: EPS Beat, Revenues Miss

<p>nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) sees Q4 sales of $49.000 million-54.000 million vs $59.88 million estimate.</p>


LASR

nLight Sees Q4 Sales $49.000M-54.000M vs $59.88M Est

<p>Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent.  The company reported quarterly sales of $65.200 million which missed the analyst consensus estimate of $67.555 million by 3.49 percent.  This is a 2.49 percent decrease over sales of $66.865 million the same period last year.</p>


Earnings Misses

MRVI

Maravai LifeSciences Q3 2024 Adj. EPS $(0.02) Misses $(0.01) Estimate, Sales $65.200M Miss $67.555M Estimate

<p>Joint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) System-wide sales are expected to be between $525 million and $535 million.</p>


JYNT

Joint Corp. FY 2024 System-wide sales are expected to be between $525 million and $535 million.

<p><strong>Updated FY2024 Guidance</strong></p>
<p>&nbsp;</p>
<ul>
<li>The Company is raising several components of its FY2024 guidance due to: 1) continued sustained growth, and 2) the inclusion of the newly launched banking program with WebBank, which was not accounted for in previous guidance.</li>
<li>&nbsp;
<ul>
<li>Net Income: $71.5 million versus $55.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Net Income per Diluted Share: $12.05 versus $9.25 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Growth: 55% versus 35%-40% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Total Revenue Less Transaction Related Costs as a percentage of Total Revenue: No change to the 55% provided with 2Q24 earnings.</li>
</ul>
</li>
<li>Additionally, updating the FY2024 guidance for the following metrics that adjust for certain significant gains, losses, and charges that may not directly correlate to the underlying performance of the Company's business:</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income<a href="http:/#_ftn2">[2]</a>: $58.0 million versus $40.0 million provided with 2Q24 earnings.</li>
</ul>
</li>
<li>&nbsp;
<ul>
<li>Adjusted Net Income per Diluted Share2: $9.80 versus $6.75 provided with 2Q24 earnings.</li>
</ul>
</li>
<li>The Company expects a mid-single digit annualized effective tax before consideration of discrete tax items for 4Q24.</li>
</ul>


Sezzle Increases FY24 Revenue Growth Guidance From 35%-40% To 55%; Adj. Net Income Per Diluted Share From $6.75 To $9.80 Vs $6.73 Est.; Adj. Net Income From $40M To $58M

<p>FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) lowers FY2024 sales outlook from $545.65 million-556.56 million to $540.19 million-545.65 million.</p>


FIGS

FIGS Lowers FY2024 Sales Guidance from $545.65M-556.56M to $540.19M-545.65M

<p>ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.79) by 26.58 percent.</p>


ALXO

ALX Oncology Holdings Q3 2024 GAAP EPS $(0.58) Beats $(0.79) Estimate

<p>CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.31) by 93.55 percent.  The company reported quarterly sales of $56.664 million which missed the analyst consensus estimate of $58.042 million by 2.37 percent.  This is a 0.90 percent increase over sales of $56.157 million the same period last year.</p>


CYRX

CryoPort Q3 2024 GAAP EPS $(0.02) Beats $(0.31) Estimate, Sales $56.664M Miss $58.042M Estimate

<p>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year.  The company reported quarterly sales of $190.00 thousand which missed the analyst consensus estimate of $2.25 million by 91.56 percent.  This is a 81.85 percent decrease over sales of $1.05 million the same period last year.</p>


MVIS

Microvision Q3 EPS $(0.07) Beats $(0.10) Estimate, Sales $190.00K Miss $2.25M Estimate

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The financial technology (FinTech) industry is forecasted to grow at an annualized rate of <a href="https://www.fortunebusinessinsights.com/fintech-market-108641" target="_blank">16.5%</a> until 2032, illustrating its potential. However, information about the bulk of financial <a href="https://investorplace.com/industries/technology/">technology stocks</a> is widely dispensed. As such, most <a href="https://investorplace.com/industries/financial/fintech/">FinTech stocks</a> are either priced in or overvalued.</p>



<p>Considering the above, I decided to embark on a journey to find three overlooked fintech stocks worth investing in. Methodologically, I focused on fundamental aspects, valuation multiples, and key operating metrics. Moreover, I emphasized event-driven elements to ensure that each stock was analyzed holistically.</p>



<p>Some investors might find FinTech stocks too risky. However, if you are willing and able to take on risk, here are three overlooked fintech stocks worth considering.</p>



<h2>MoneyLion (ML)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/moneylion-fuse-1600-300x169.jpg" alt="MoneyLion Iphone Display"><div>Source: Sulastri Sulastri / Shutterstock.com</div></div><p><strong>MoneyLion</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/ml-stock-quote/"><strong>ML</strong></a></span>) is a loan intermediary servicing lower credit score borrowers. The company operates a novel business model, integrated with more than <a href="https://d1io3yog0oux5.cloudfront.net/_aa329c02c6b801b61f0daec1556d57f0/moneylion/db/1912/17912/pdf/Q1+2024+Earnings+Presentation_vF.pdf">1,100 external partners</a> to facilitate fee-based loan revenue, advertising revenue, and subscription-geared income. Moreover, MoneyLion has adopted best-in-class machine learning technology, allowing it to assess numerous data points before intermediating loans or adopting an advertiser onto its platform.</p>



<p>The company recently proved its worth when it released its first-quarter earnings report. MoneyLion exceeded its revenue estimate by <a href="https://seekingalpha.com/news/4101031-moneylion-gaap-eps-of-0_60-beats-0_68-revenue-of-121m-beats-4_69m?source=content_type%3Areact%7Csection%3Asummary%7Csection_asset%3Aall_news%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A5">$4.69 million</a>. Additionally, its earnings-per-share settled 68 cents above target, conveying its bottom-line efficiency.</p>



<p>According to CNN, ML stock has merely <a href="https://edition.cnn.com/markets/stocks/ML">four ratings</a> from Wall Street, illustrating that it has yet to draw the attention of most analysts. Moreover, key metrics suggest that ML stock is grossly undervalued. For example, it has a price-to-sales ratio of merely <a href="https://finance.yahoo.com/quote/ML/key-statistics/">1.7x</a>, which is low for a growth stock.</p>



<p>I&rsquo;m bullish here!</p>



<h2>NerdWallet (NRDS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/11/nrds-stock-1-300x169.jpg" alt="The NerdWallet (NRDS) logo displayed on a computer screen."><div>Source: monticello / Shutterstock.com</div></div><p><strong>NerdWallet</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/nrds-stock-quote/"><strong>NRDS</strong></a></span>) operates a financial information platform. The firm&rsquo;s platform compares and assesses numerous financial products ranging from personal finance to niche investing. Although NRDS stock probably won&rsquo;t achieve mega-cap status, its business model is aligned with today&rsquo;s world, which includes growth in retail investor participation and demand for financial literacy. As such, I think NRDS stock can reach new heights in the coming years.</p>



<p>As for its key metrics, NerdWallet possesses a scintillating three-year compound annual growth rate of <a href="https://seekingalpha.com/symbol/NRDS/growth">34.19%</a>. Moreover, NerdWallet has a gross profit margin of <a href="https://seekingalpha.com/symbol/NRDS/profitability">90.81%</a>, suggesting it has inflation pass-through abilities. Sure, the company has yet to achieve profitability. However, it remains focused on growth and will likely emphasize shareholders&rsquo; residual value when the time is right.</p>



<p>According to MarketWatch, NRDS stock has <a href="https://www.marketwatch.com/investing/stock/nrds/analystestimates">seven Wall Street ratings</a>. Although this is not a negligent number of ratings, it remains low, suggesting NRDS stock has yet to gain much traction among Wall Street analysts. Moreover, NRDS stock has a price-to-sales ratio of <a href="https://finance.yahoo.com/quote/NRDS/key-statistics/">1.8x</a>, implying that it is undervalued, especially given its resilient growth rate.</p>



<h2>Hippo Holdings (HIPO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/06/health_insurance_1600-300x169.jpg" alt="A health insurance claim form with a stethoscope, a calculator, and several hundred dollar bills resting on top."><div>Source: Valeri Potapova / Shutterstock.com</div></div><p><strong>Hippo Holdings</strong> (NYSE:<strong><a target="_blank" href="https://investorplace.com/stock-quotes/hipo-stock-quote/">HIPO</a></strong>) is an insurance technology company geared toward short-term solutions such as property and casualty insurance. I&rsquo;m a massive fan of online insurance technology as it addresses consumer convenience. Moreover, Hippo has formed a comprehensive suite of partnerships, allowing it to benefit from synergies while providing its customers with an integrated process.</p>



<p>The company proved its worth upon releasing its first-quarter fiscal report in May. Hippo strolled past estimates by delivering a revenue beat of <a target="_blank" href="https://seekingalpha.com/news/4098373-hippo-holdings-reports-q1-results?source=content_type%3Areact%7Csection%3Asummary%7Csection_asset%3Aall_news%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A2">$12.12 million</a>, a 1.14x year-over-year increase! Moreover, Hippo trimmed its net loss by 49% to $36 million.</p>



<p>Similar to the other stocks mentioned in this article, HIPO has earned a low of outstanding Wall Street ratings. In fact, it has merely <a target="_blank" href="https://www.marketwatch.com/investing/stock/hipo/analystestimates">five ratings</a> from Wall Street analysts, showing that it is somewhat under the radar. Additionally, HIPO stock&rsquo;s price-to-sales ratio of 1.5x, which is low if one considers its secular growth attributes.</p>



<p><em>On the date of publication, Steve Booyens did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.</em></p>
<div><p>Steve Booyens co-founded Pearl Gray Equity and Research in 2020 and has been responsible for cross-asset research and PR ever since. Before founding the firm, Steve spent time working in various finance roles in London and South Africa. He holds an MSc in Investment Banking from Queen Mary &ndash; University of London. Furthermore, Steve obtained his CFA Charter on April 26, 2024, and is working toward his Ph.D. in Finance. His articles are published on various reputable web pages such as Seeking Alpha, TipRanks, Yahoo Finance, and Benzinga. Steve&rsquo;s articles on InvestorPlace form an interesting juxtaposition between mainstream opinion and objective theory. Readers can expect coverage on frequently traded stocks, REITs, fixed-income funds, CEFs, and ETFs.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/treasure-hunt-3-fintech-stocks-wall-street-hasnt-discovered-yet/">Treasure Hunt: 3 Fintech Stocks Wall Street Hasn&#8217;t Discovered Yet</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Treasure Hunt: 3 Fintech Stocks Wall Street Hasn't Discovered Yet

Jefferies analyst Yaron Kinar maintained a Buy rating on Hippo Holdings (HIPO – Research Report) today and set a price target of $24.00. The compan...

Jefferies Sticks to Their Buy Rating for Hippo Holdings (HIPO)

Hippo Holdings Q2 2024 Earnings Preview

Hippo Holdings reports Q2 results

Hippo Holdings, Inc. (HIPO) Q2 2024 Earnings Call Transcript

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Hippo Holdings</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/hipo-stock-quote/"><strong>HIPO</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Hippo Holdings reported earnings per share of -$1.64. This was below the analyst estimate for EPS of -$1.45.</li><li>The company reported revenue of $89.60 million.</li><li>This was 2.55% better than the analyst estimate for revenue of $87.37 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/hipo-stock-earnings-hippo-holdings-for-q2-of-2024/">HIPO Stock Earnings: Hippo Holdings Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

HIPO Stock Earnings: Hippo Holdings Misses EPS, Beats Revenue for Q2 2024

In a report released yesterday, Thomas McJoynt Griffith from KBW maintained a Hold rating on Hippo Holdings (HIPO – Research Report), with a price ...

KBW Remains a Hold on Hippo Holdings (HIPO)

JMP Securities analyst Matthew Carletti reiterated a Buy rating on Hippo Holdings (HIPO – Research Report) today and set a price target of $25.00. ...

JMP Securities Reaffirms Their Buy Rating on Hippo Holdings (HIPO)

KBW analyst Thomas McJoynt Griffith maintained a Hold rating on Hippo Holdings (HIPO – Research Report) yesterday and set a price target of $21.00....

KBW Sticks to Their Hold Rating for Hippo Holdings (HIPO)

Hippo Holdings ( ($HIPO) ) has provided an announcement. Yuval Harry, the former Chief Revenue Officer of Hippo Holdings Inc., is set to leave his ...

Hippo Holdings CRO Transition with Consulting Continuation

HIPO

NRDS

Insurance

Press Releases

Hippo Reports Fourth Quarter 2023 Financial Results

Hippo's First Connect Hits 100 Carrier & MGA Milestone and Launches New Appetite Finder Feature

HIPPO TO REPORT FIRST QUARTER FINANCIAL RESULTS ON MAY 2, 2024

Vareto Introduces First Multiplayer Platform In Enterprise Planning Category

Hippo Reports First Quarter 2024 Financial Results

HIPPO TO REPORT SECOND QUARTER FINANCIAL RESULTS ON AUGUST 8, 2024

Hippo Reports Second Quarter 2024 Financial Results

Real Estate

Hippo Expands Home Builder Access to New Homes Program in California, Florida, and Texas

Hippo Appoints William Malone as Vice President, Head of Agency

HIPPO TO REPORT THIRD QUARTER FINANCIAL RESULTS ON NOVEMBER 8, 2024

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Hippo Holdings

Vendite allo scoperto

Hippo Holdings (NYSE:HIPO) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO